DF Dent & Co’s RxSight RXST Stock Holding History

DF Dent & Co’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-421,061	Closed	-$10.6M	–	267
2025 Q1	$10.6M	Sell	421,061 -1,385	-0.3%	-$41.2K	0.14%	98
2024 Q4	$14.5M	Buy	+422,446	New	+$19.1M	0.18%	93

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DF Dent & Co's RXST Position: Q2 2025 in Review

DF Dent & Co sold out of RxSight (RXST) in Q2 2025, closing a stake of 421,061 shares — an estimated $10.6M sold.

DF Dent & Co first reported a position in RXST in Q4 2024 and held it in 2 quarters. The position peaked at $14.5M in Q4 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

DF Dent & Co reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
DF Dent & Co sold 421,061 RxSight shares in Q2 2025, an estimated $10.6M.
DF Dent & Co first reported a position in RxSight in Q4 2024 and held it in 2 quarters.
DF Dent & Co's RxSight position peaked at $14.5M in Q4 2024.
174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on DF Dent & Co's 13F filing for Q2 2025, filed 14 Aug 2025.